Correlation Between Vertex Pharmaceuticals and Basilea Pharmaceutica

Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and Basilea Pharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and Basilea Pharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vertex Pharmaceuticals and Basilea Pharmaceutica AG, you can compare the effects of market volatilities on Vertex Pharmaceuticals and Basilea Pharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of Basilea Pharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and Basilea Pharmaceutica.

Diversification Opportunities for Vertex Pharmaceuticals and Basilea Pharmaceutica

-0.78

Correlation Coefficient

Vertex Pharmaceuticals  Basilea Pharmaceutica

Pay attention - limited upside

The 3 months correlation between Vertex and Basilea is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals and Basilea Pharmaceutica AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Basilea Pharmaceutica and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals are associated (or correlated) with Basilea Pharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Basilea Pharmaceutica has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and Basilea Pharmaceutica go up and down completely randomly.

Pair Corralation between Vertex Pharmaceuticals and Basilea Pharmaceutica

Given the investment horizon of 90 days Vertex Pharmaceuticals is expected to generate 1.09 times more return on investment than Basilea Pharmaceutica. However, Vertex Pharmaceuticals is 1.09 times more volatile than Basilea Pharmaceutica AG. It trades about 0.06 of its potential returns per unit of risk. Basilea Pharmaceutica AG is currently generating about 0.02 per unit of risk. If you would invest  25,417  in Vertex Pharmaceuticals on February 3, 2024 and sell it today you would earn a total of  14,599  from holding Vertex Pharmaceuticals or generate 57.44% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Vertex Pharmaceuticals  vs.  Basilea Pharmaceutica AG

Vertex Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vertex Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Basilea Pharmaceutica

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Basilea Pharmaceutica AG are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Basilea Pharmaceutica reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Vertex Pharmaceuticals and Basilea Pharmaceutica

The main advantage of trading using opposite Vertex Pharmaceuticals and Basilea Pharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, Basilea Pharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Basilea Pharmaceutica will offset losses from the drop in Basilea Pharmaceutica's long position.

The idea behind Vertex Pharmaceuticals and Basilea Pharmaceutica AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.